Healthcare Triangle, Inc. (Nasdaq: HCTI), a U.S.-based healthcare technology company, announced that it has become the U.S. technology and capital-markets partner for the newly launched Kanzun-ARCB Growth Fund. The fund was created through a memorandum of understanding signed in Kuala Lumpur, Malaysia. It pairs Dubai-based ARCB Investment LLC with Malaysia's Kanzun Ventures Management to connect Malaysian healthcare firms to global capital.
Strategic Objectives of the Partnership
The collaboration establishes a structured corridor linking Malaysian healthcare companies to Middle Eastern capital and, ultimately, to U.S. capital markets. ARCB brings approximately AED 300 million in assets under management and a broad network of family offices and institutional investors across the Middle East and Asia. The fund marks ARCB's first major platform launch in the Asia-Pacific region since opening its Kuala Lumpur office in April 2026.
How the Collaboration Will Work
Kanzun will lead deal sourcing, due diligence, valuation, and portfolio development in Malaysia by identifying healthcare companies with strong growth potential. ARCB will anchor the fund's capital formation by drawing on its investor relationships across the Middle East and Asia. HCTI will step in when target companies are ready for their next stage of growth, applying its Nasdaq-listed experience and expertise in artificial intelligence, cloud, data, and digital infrastructure.
Executive Commentary
HCTI's Founder and Head of M&A, Dr. Suresh Venkatachari, said the company is pleased to collaborate with ARCB and Kanzun Ventures in evaluating opportunities within Malaysia's AI and healthcare sector. ARCB Group Chief Executive Officer Dr. Chaskar U. said the partnership is building a corridor that connects Malaysian healthcare champions to Middle Eastern capital and then to U.S. capital markets. Kanzun Ventures CEO Loganathan S. added that the collaboration provides access to an international capital network and an important connection to healthcare technology and the U.S. market.
About Healthcare Triangle
Healthcare Triangle is based in Pleasanton, California, and reinforces healthcare progress through breakthrough technology and extensive industry knowledge and expertise. It supports hospitals, health systems, payers, and pharmaceutical and life sciences organizations in improving health outcomes through better use of the data and information technologies they rely on. Its Cloud and Data Platform, marketed as CloudEz and DataEz, has achieved HITRUST Risk-based 2-year certified status, demonstrating the highest standards for data protection and information security.
About ARCB and Kanzun
ARCB Investment LLC is a UAE fund house established in 2022 and licensed by the Mainland investment management authority under License No. 1041252. It manages approximately AED 300 million in assets across ten sectors including energy, water, healthcare, education, and technology, and is a participant of the United Nations Global Compact. Kanzun Ventures Management is a Malaysia-based venture capital management corporation registered with the Securities Commission Malaysia, focused on developing investment opportunities with significant growth potential.
Market Significance
This initiative arrives as cross-border investment in healthcare technology continues to expand across emerging markets. The partnership combines local deal execution, Middle Eastern capital, and U.S. market preparation in a single coordinated investment framework. By bridging these regions, the fund aims to help Malaysian healthcare companies meet the sophisticated governance, technology, and financial standards expected by international investors.
The Kanzun-ARCB Growth Fund represents a coordinated effort to unlock latent value in Malaysia's healthcare sector through structured international collaboration. HCTI's role as technology and capital-markets partner adds a practical pathway for companies seeking to enter U.S. markets with stronger digital infrastructure and governance. The partnership signals growing confidence in Southeast Asian healthcare innovation and its potential to attract institutional investment from the Middle East and the United States.